Albendazole-induced recurrent hepatitis

Indian Pediatrics

Volumn 50, Issue 11, 2013, Pages 1064-

  Nandi, Madhumita ^a   Sarkar, Sumantra ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBENDAZOLE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CERULOPLASMIN; GAMMA GLUTAMYLTRANSFERASE;

ACUTE HEPATITIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANOREXIA; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CERULOPLASMIN BLOOD LEVEL; CHILD; CHILDHOOD DISEASE; DISEASE DURATION; EYE COLOR; FEVER; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATOMEGALY; HUMAN; JAUNDICE; LETTER; MALE; PRESCHOOL CHILD; PROTHROMBIN TIME; RECURRENT INFECTION; URINE COLOR; VOMITING;

ACUTE DISEASE; ALBENDAZOLE; BILIRUBIN; CHILD, PRESCHOOL; DRUG-INDUCED LIVER INJURY; HUMANS; MALE;

EID: 84890492241     PISSN: 00196061     EISSN: 09747559     Source Type: Journal    
DOI: 10.1007/s13312-013-0285-8     Document Type: Letter

References (5)

1. Gozukucuk R, Abci I, Gluclu M. Albendazole-induced toxic hepatitis: A case report. Turk J Gastroenterol. 2013;24:82-83.
2. Shah C, Mahapatra A, Shukla A, Bhatia S. Recurrent acute hepatitis caused by albendazole. Trop Gastroenterol. 2013;34:38-39.
3. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
4. Danan G, Be'nichou C. Causality assessment of adverse reactions to drugs: I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol. 1993;46:1323-1330.
5. Be'nichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs: II. An original novel or validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol.